Information Journal Paper
APA:
Copy. (2017). Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice. DIABETES OBESITY AND METABOLISM, 19(10), 1468-1472. SID. https://sid.ir/paper/728137/en
Vancouver:
Copy. Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice. DIABETES OBESITY AND METABOLISM[Internet]. 2017;19(10):1468-1472. Available from: https://sid.ir/paper/728137/en
IEEE:
Copy, “Dual CCR2/CCR5 antagonist treatment attenuates adipose inflammation, but not microvascular complications in ob/ob mice,” DIABETES OBESITY AND METABOLISM, vol. 19, no. 10, pp. 1468–1472, 2017, [Online]. Available: https://sid.ir/paper/728137/en